BACKGROUND & AIMS: We investigated whether risk for non-insulin-dependent diabetes mellitus (NIDDM) and metabolic syndrome are affected by celiac disease. We examined the prevalence of NIDDM and metabolic syndrome among adults with celiac disease, compared with matched controls. METHODS: We assessed medical records of 840 patients with biopsy-proven celiac disease for diagnoses of NIDDM, hypertension, or hyperlipidemia; body mass index (BMI); lipid profile; and levels of glucose or glycosylated hemoglobin, to identify those with metabolic syndrome. Patients without celiac disease were matched for age, sex, and ethnicity (n = 840 controls). The prevalence of NIDDM and metabolic syndrome in the celiac disease cohort was compared with that of the controls and subjects included in the National Health and Nutrition Examination Survey. RESULTS: Twenty-six patients with celiac disease (3.1%) had NIDDM compared with 81 controls (9.6%) (P < .0001). Similarly, the prevalence of metabolic syndrome was significantly lower among patients with celiac disease than controls (3.5% vs 12.7%; P < .0001). The mean BMI of patients with celiac disease was significantly lower than that of controls (24.7 vs 27.5; P < .0001). However, celiac disease was still associated with a lower risk of NIDDM, after controlling for BMI. CONCLUSIONS: The prevalence of NIDDM and metabolic syndrome are lower among patients with celiac disease than in matched controls and the general population. These differences are not explained by differences in BMI. Studies are needed to determine the mechanisms by which celiac disease affects the risk for NIDDM and metabolic syndrome.
BACKGROUND & AIMS: We investigated whether risk for non-insulin-dependent diabetes mellitus (NIDDM) and metabolic syndrome are affected by celiac disease. We examined the prevalence of NIDDM and metabolic syndrome among adults with celiac disease, compared with matched controls. METHODS: We assessed medical records of 840 patients with biopsy-proven celiac disease for diagnoses of NIDDM, hypertension, or hyperlipidemia; body mass index (BMI); lipid profile; and levels of glucose or glycosylated hemoglobin, to identify those with metabolic syndrome. Patients without celiac disease were matched for age, sex, and ethnicity (n = 840 controls). The prevalence of NIDDM and metabolic syndrome in the celiac disease cohort was compared with that of the controls and subjects included in the National Health and Nutrition Examination Survey. RESULTS: Twenty-six patients with celiac disease (3.1%) had NIDDM compared with 81 controls (9.6%) (P < .0001). Similarly, the prevalence of metabolic syndrome was significantly lower among patients with celiac disease than controls (3.5% vs 12.7%; P < .0001). The mean BMI of patients with celiac disease was significantly lower than that of controls (24.7 vs 27.5; P < .0001). However, celiac disease was still associated with a lower risk of NIDDM, after controlling for BMI. CONCLUSIONS: The prevalence of NIDDM and metabolic syndrome are lower among patients with celiac disease than in matched controls and the general population. These differences are not explained by differences in BMI. Studies are needed to determine the mechanisms by which celiac disease affects the risk for NIDDM and metabolic syndrome.
Authors: S Lohi; K Mustalahti; K Kaukinen; K Laurila; P Collin; H Rissanen; O Lohi; E Bravi; M Gasparin; A Reunanen; M Mäki Journal: Aliment Pharmacol Ther Date: 2007-11-01 Impact factor: 8.171
Authors: Alberto Rubio-Tapia; Mussarat W Rahim; Jacalyn A See; Brian D Lahr; Tsung-Teh Wu; Joseph A Murray Journal: Am J Gastroenterol Date: 2010-02-09 Impact factor: 10.864
Authors: Gertraud Maskarinec; Andrew Grandinetti; Grace Matsuura; Sangita Sharma; Marjorie Mau; Brian E Henderson; Laurence N Kolonel Journal: Ethn Dis Date: 2009 Impact factor: 1.847
Authors: Alberto Rubio-Tapia; Robert A Kyle; Edward L Kaplan; Dwight R Johnson; William Page; Frederick Erdtmann; Tricia L Brantner; W Ray Kim; Tara K Phelps; Brian D Lahr; Alan R Zinsmeister; L Joseph Melton; Joseph A Murray Journal: Gastroenterology Date: 2009-04-10 Impact factor: 22.682
Authors: Christina C Wee; Mary Beth Hamel; Annong Huang; Roger B Davis; Murray A Mittleman; Ellen P McCarthy Journal: Diabetes Care Date: 2008-05-28 Impact factor: 19.112
Authors: Norelle R Reilly; Benjamin Lebwohl; Rolf Hultcrantz; Peter H R Green; Jonas F Ludvigsson Journal: J Hepatol Date: 2015-01-21 Impact factor: 25.083
Authors: Anna Tavakkoli; Suzanne K Lewis; Christina A Tennyson; Benjamin Lebwohl; Peter H R Green Journal: Dig Dis Sci Date: 2013-12-28 Impact factor: 3.199
Authors: Benjamin Lebwohl; Louise Emilsson; Ole Fröbert; Andrew J Einstein; Peter H R Green; Jonas F Ludvigsson Journal: PLoS One Date: 2015-01-30 Impact factor: 3.240
Authors: Walter F Tetzlaff; Tomás Meroño; Martin Menafra; Maximiliano Martin; Eliana Botta; Maria D Matoso; Patricia Sorroche; Juan A De Paula; Laura E Boero; Fernando Brites Journal: World J Cardiol Date: 2017-05-26
Authors: Roman M Janas; Anna Rybak; Aldona Wierzbicka-Rucińska; Piotr Socha; Rafał Śnitko; Anna Szaflarska-Popławska; Anna Stolarczyk; Beata Oralewska; Elżbieta Cytra-Jarocka; Barbara Iwańczak; Urszula Grzybowska-Chlebowczyk; Wojciech Cichy; Grażyna Czaja-Bulsa; Jerzy Socha Journal: Gut Liver Date: 2016-07-15 Impact factor: 4.519